🇺🇸 FDA
Patent

US 8735355

Methods of use of fragments of secreted frizzled related protein, sFRP

granted A61KA61K38/00A61P

Quick answer

US patent 8735355 (Methods of use of fragments of secreted frizzled related protein, sFRP) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/00, A61P, A61P35/00, A61P43/00